Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 3, 2014, Pages 641-645

  Thotakura, Mahathi ^a   Tirumalasetti, Neelima ^a   Krishna, Ravi ^a  

^a NRI Medical College   (India)

Author keywords

Astrocytoma; immunohistochemistry Ki 67; proliferation markers

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PROGNOSIS; CELL PROLIFERATION; CHILD; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; WORLD HEALTH ORGANIZATION; BRAIN TUMOR; IMMUNOHISTOCHEMISTRY; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; YOUNG ADULT;

EID: 84920768690     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.139154     Document Type: Article

References (28)

1. Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. 3rd ed. Lyon, France: IARC Press; 2000. p. 314.
2. Gudinaviciene I, Pranys D, Juozaityte E. Impact of morphology and biology on the prognosis of patients with gliomas. Medicina (Kaunas) 2004;40:112-20.
3. Haberland C. Clinical neuropathology: Text and color atlas. In: Percy C, editor. Tumors of the Central Nervous System. New York: Demos Medical Publishing, LLC; 2007. p. 213.
4. Hsu CY, Ho DM, Yang CF, Chiang H. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods. Mod Pathol 2003;16:951-7.
5. Wakimoto H, Aoyagi M, Nakayama T, Nagashima G, Yamamoto S, Tamaki M, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996;77:373-80.
6. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns BJ, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-8.
7. Ganju V, Jenkins RB et al. Prognostic factors in gliomas. A multivariate analysis of clinic pathologic, flow cytometric, cytogenetic and molecular markers. Cancer 1994;74:920-7
8. Whitton AC, Bloom HJ. Low grade glioma of the cerebral hemispheres in adults: A retrospective analysis of 88 cases. Int J Radiat Oncol Biol Phys 1990;18:783-6.
9. Jaskólsky D, Zawirski M, Papierz W, Kotwica Z. Mixed gliomas. Their clinical course and results of surgery. Zentralbl Neurochir 1987;48:120-3.
10. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, et al. Cancer surveillance series [corrected]: Brain and other central nervous system cancers: Recent trends in incidence and mortality. J Natl Cancer Inst 1999;91:1382-90.
11. Burkhard C, Di Patre PL, Schüler D, Schüler G, Yasargil MG, Yonekawa Y, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 2003;98:1170-4.
12. Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 1995;17:382-414.
13. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
14. Wang HC, Ho YS. Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system. J Neurooncol 1992;13:265-76.
15. Lakhtakia R, Trehan A, Rai R, Mukherjee S. Astrocytomas and prognosis-From morphology to tumor biology. Med J Armed Forces India 2000;56:103-9.
16. Zulch KJ. Histologic typing of tumours of the central nervous system. In: Zulch KJ, editor. International Histological Classification of Tumours, No. 21. Geneva: World Health Organization; 1979. p. 17-57.
17. Suri VS, Tatke M, Singh D, Sharma A. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype. Indian J Cancer 2004;41:66-71.
18. Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 2004;146:37-44.
19. Rathi KR, Radotra BD, Khosla VK. Proliferative index in astrocytic tumours. Indian J Pathol Microbiol 2007;50:754-8.
20. Tibbetts KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR. Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathol 2009;117:657-65.
21. Ambroise MM, Khosla C, Ghosh M, Mallikarjuna VS, Annapurneswari S. Practical value of MIB-1 index in predicting behavior of astrocytomas. Indian J Pathol Microbiol 2011;54:520-5.
22. Bowers DC, Gargan L, Kapur P, Reisch JS, Mulne AF, Shapiro KN, et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 2003;21:2968-73.
23. Klein R, Roggendorf W. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: A double labeling study. Acta Neuropathol 2001;101:245-8.
24. Rodriguez-Pereira C, Suarez-Penaranda JM, Vazquez-Salvado M, Sobrido MJ, Abraldes M, Barros F, et al. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study. J Neurosurg Sci 2000;44:203-9.
25. Hsu DW, Louis DN, Efird JT, Hedley-Whyte ET. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 1997;56:857-65.
26. Moskowitz SI, Jin T, Prayson RA. Role of MIB1 in predicting survival in patients with glioblastomas. J Neurooncol 2006;76:193-200.
27. Tihan T, Davis R, Elowitz E, DiCostanzo D, Moll U. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. Arch Pathol Lab Med 2000;124:108-13.
28. Ralte AM, Sharma MC, Karak AK, Mehta VS, Sarkar C. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors. Pathol Oncol Res 2001;7:267-78.